TBC
MDCO

Three Bays Capital’s Medicines Co MDCO Stock Holding History

Three Bays Capital’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,849,822
Closed -$55.3M – 19
2018
Q3 		$55.3M Buy
1,849,822
+489,262
+36% +$18.4M 6.52% 7
2018
Q2 		$49.9M Sell
1,360,560
-373,932
-22% -$12.2M 1.94% 17
2018
Q1 		$57.1M Sell
1,734,492
-821,774
-32% -$25.7M 3.96% 9
2017
Q4 		$69.9M Buy
2,556,266
+979,863
+62% +$30.2M 3.93% 9
2017
Q3 		$58.4M Buy
1,576,403
+113,000
+8% +$4.17M 4.34% 12
2017
Q2 		$55.6M Buy
1,463,403
+99,874
+7% +$4.45M 4.43% 10
2017
Q1 		$66.7M Buy
+1,363,529
New +$62.2M 5.46% 7

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Three Bays Capital's MDCO Position: Q4 2018 in Review

Three Bays Capital sold out of Medicines Co (MDCO) in Q4 2018, closing a stake of 1,849,822 shares — an estimated $55.3M sold.

Three Bays Capital first reported a position in MDCO in Q1 2017 and held it in 7 quarters. The position peaked at $69.9M in Q4 2017. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

  • Three Bays Capital reported no remaining Medicines Co position as of Q4 2018 after selling out during the quarter.
  • Three Bays Capital sold 1,849,822 Medicines Co shares in Q4 2018, an estimated $55.3M.
  • Three Bays Capital first reported a position in Medicines Co in Q1 2017 and held it in 7 quarters.
  • Three Bays Capital's Medicines Co position peaked at $69.9M in Q4 2017.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on Three Bays Capital's 13F filing for Q4 2018.